AT346476B - Verfahren zur herstellung einer vakzine zur immunisierung von gefluegel gegen die marek'schekrankheit - Google Patents

Verfahren zur herstellung einer vakzine zur immunisierung von gefluegel gegen die marek'schekrankheit

Info

Publication number
AT346476B
AT346476B AT600274A AT600274A AT346476B AT 346476 B AT346476 B AT 346476B AT 600274 A AT600274 A AT 600274A AT 600274 A AT600274 A AT 600274A AT 346476 B AT346476 B AT 346476B
Authority
AT
Austria
Prior art keywords
vaccine
disease
producing
poultry against
against marek
Prior art date
Application number
AT600274A
Other languages
English (en)
Other versions
ATA600274A (de
Original Assignee
Sevoian Martin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sevoian Martin filed Critical Sevoian Martin
Publication of ATA600274A publication Critical patent/ATA600274A/de
Application granted granted Critical
Publication of AT346476B publication Critical patent/AT346476B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT600274A 1973-07-19 1974-07-19 Verfahren zur herstellung einer vakzine zur immunisierung von gefluegel gegen die marek'schekrankheit AT346476B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38061573A 1973-07-19 1973-07-19

Publications (2)

Publication Number Publication Date
ATA600274A ATA600274A (de) 1978-03-15
AT346476B true AT346476B (de) 1978-11-10

Family

ID=23501855

Family Applications (1)

Application Number Title Priority Date Filing Date
AT600274A AT346476B (de) 1973-07-19 1974-07-19 Verfahren zur herstellung einer vakzine zur immunisierung von gefluegel gegen die marek'schekrankheit

Country Status (18)

Country Link
JP (1) JPS5052227A (de)
AR (1) AR201878A1 (de)
AT (1) AT346476B (de)
AU (1) AU7096274A (de)
BE (1) BE817865A (de)
DE (1) DE2434515A1 (de)
DK (1) DK137931B (de)
ES (1) ES428370A1 (de)
FI (1) FI219974A (de)
FR (1) FR2301268A1 (de)
GB (1) GB1481847A (de)
IE (1) IE40159B1 (de)
IL (1) IL45181A0 (de)
IT (1) IT1017330B (de)
NL (1) NL7409842A (de)
NO (1) NO742557L (de)
SE (1) SE7409411L (de)
ZA (1) ZA743771B (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000811A1 (en) * 1984-07-30 1986-02-13 Csatary Laszlo Therapeutic preparations for treatment of certain viral and other diseases and the preparation of the same
EP0253389A1 (de) * 1986-07-17 1988-01-20 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Lebendvaccine für Ansteckungskrankheiten von Küken

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114717200B (zh) * 2022-03-16 2023-03-24 河南省农业科学院 一株马立克病病毒特超强毒株及其基因缺失毒株的构建和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1941373B1 (de) * 1969-08-14 1970-11-19 Lohmann & Co Kg Verfahren zur Herstellung einer Lebendvakzine gegen die Mareksche Krankheit der Huehner
JPS5013333B1 (de) * 1970-04-22 1975-05-19

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000811A1 (en) * 1984-07-30 1986-02-13 Csatary Laszlo Therapeutic preparations for treatment of certain viral and other diseases and the preparation of the same
EP0253389A1 (de) * 1986-07-17 1988-01-20 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Lebendvaccine für Ansteckungskrankheiten von Küken

Also Published As

Publication number Publication date
NL7409842A (nl) 1975-01-21
NO742557L (de) 1975-02-17
ZA743771B (en) 1975-07-30
SE7409411L (de) 1975-01-20
BE817865A (fr) 1974-11-18
JPS5052227A (de) 1975-05-09
IL45181A0 (en) 1974-10-22
ES428370A1 (es) 1976-09-16
AR201878A1 (es) 1975-04-24
FR2301268B1 (de) 1978-07-21
FI219974A (de) 1975-01-20
IT1017330B (it) 1977-07-20
ATA600274A (de) 1978-03-15
IE40159B1 (en) 1979-03-28
DE2434515A1 (de) 1975-03-27
FR2301268A1 (fr) 1976-09-17
IE40159L (en) 1975-01-19
DK137931C (de) 1978-10-30
DK137931B (da) 1978-06-05
AU7096274A (en) 1976-01-08
GB1481847A (en) 1977-08-03
DK389574A (de) 1975-03-10

Similar Documents

Publication Publication Date Title
AT366419B (de) Verfahren zur herstellung einer dispersionsverstaerkten aluminiumlegierung
AT335061B (de) Verfahren zur herstellung von neuen cephalosporinen
AT342045B (de) Verfahren zur herstellung von neuen 1,1-diaryl-1-oxadiazolalkylaminen
AT363178B (de) Verfahren zur herstellung einer stabilen wasser -in-oel-emulsion fuer die zubereitung von adjuvanspraeparaten fuer impfstoffe bzw. von impfstoffen
AT358166B (de) Verfahren zur herstellung einer verbesserten vakzine gegen newcastle-krankheit
AT334530B (de) Verfahren zur herstellung von neuen 1,3-oxazino (5,6-c) rifamycinen
DD131762A5 (de) Verfahren zur herstellung eines pferde-rhinopneumonievakzins
AT359643B (de) Verfahren zur herstellung von neuen 4"-ery- thromycin-a-derivaten
AT317606B (de) Verfahren zur Immunisierung von Geflügel gegen die Marek'sche Krankheit
CH548451A (de) Verfahren zur herstellung eines virusimpfstoffes gegen das kaelberdiarrhoevirus.
AT367432B (de) Verfahren zur herstellung von neuen 3",4"diacyltylosinderivaten
AT346476B (de) Verfahren zur herstellung einer vakzine zur immunisierung von gefluegel gegen die marek'schekrankheit
AT341540B (de) Verfahren zur herstellung von neuen 1,3-dialkyl-7-aminoalkylxanthinen
ATA144279A (de) Verfahren zur herstellung von neuen n-aryl-1,3- oxazolidin-2,4-dionen
ATA219179A (de) Verfahren zur herstellung von neuen demethyl- maytansinoiden
PT66097B (de) Verfahren zur herstellung einer vaccine gegen die panleukopenie der katze
AT387392B (de) Verfahren zur herstellung von 1alpha, 3betadihydroxy-delta 5-steroiden
AT334524B (de) Verfahren zur herstellung einer virus-untereinheiten-vaccine
AT369019B (de) Verfahren zur herstellung von neuen 5-niedrigalkal-2'-desoxyuridin-5'-monophosphaten
CH542928A (de) Verfahren zur Herstellung einer neuen Typhus-Vakzine
AT343627B (de) Verfahren zur herstellung neuer 2-amino-3- (3'-hydroxyphenyl) -propanole-(1)
AT331999B (de) Verfahren zur herstellung von 2,2'-anhydro-1beta-d-arabinofuranosyl-5-fluorcytosin
AT333956B (de) Verfahren zur herstellung von neuen cephalosporinen
AT341669B (de) Verfahren zur herstellung von neuen 3,4-dicarboxycephalosporinen
AT336186B (de) Verfahren zur herstellung von 3',4'-didesoxykanamycin b

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee